These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21716661

  • 1. Next-generation sequencing of microRNAs for breast cancer detection.
    Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q.
    J Biomed Biotechnol; 2011; 2011():597145. PubMed ID: 21716661
    [Abstract] [Full Text] [Related]

  • 2. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q, Wang C, Lu Z, Guo L, Ge Q.
    Clin Chim Acta; 2012 Jul 11; 413(13-14):1058-65. PubMed ID: 22387599
    [Abstract] [Full Text] [Related]

  • 3. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
    Eissa S, Matboli M, Shehata HH.
    Transl Res; 2015 Mar 11; 165(3):417-27. PubMed ID: 25445205
    [Abstract] [Full Text] [Related]

  • 4. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 11; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 5. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012 Jul 11; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 6. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
    Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H, Wang J, Yuan YC, Frankel P, Li S, Ashing-Giwa KT, Sun G, Wang Y, Smith R, Robinson K, Ren X, Wang SE.
    J Transl Med; 2012 Mar 08; 10():42. PubMed ID: 22400902
    [Abstract] [Full Text] [Related]

  • 7. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 8. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.
    Breast Cancer Res Treat; 2015 Nov 01; 154(2):423-34. PubMed ID: 26476723
    [Abstract] [Full Text] [Related]

  • 9. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
    Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.
    Dis Markers; 2013 Nov 01; 34(3):163-9. PubMed ID: 23334650
    [Abstract] [Full Text] [Related]

  • 10. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
    McDermott AM, Kerin MJ, Miller N.
    PLoS One; 2013 Nov 01; 8(12):e83718. PubMed ID: 24391813
    [Abstract] [Full Text] [Related]

  • 11. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 12. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A, Intabli H, Alkhayal W, Eltabache C, Tweigieri T, Amer SB.
    BMC Cancer; 2017 Nov 28; 17(1):799. PubMed ID: 29183284
    [Abstract] [Full Text] [Related]

  • 13. Identification of circulating microRNA signatures for breast cancer detection.
    Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.
    Clin Cancer Res; 2013 Aug 15; 19(16):4477-87. PubMed ID: 23797906
    [Abstract] [Full Text] [Related]

  • 14. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.
    Breast Cancer Res; 2012 Feb 21; 14(1):R34. PubMed ID: 22353773
    [Abstract] [Full Text] [Related]

  • 15. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching PA, Fehm T, Schneeweiss A, Beck T, Lorenz R, Friedl TWP, Janni W, Rack B, SUCCESS Study Group.
    BMC Cancer; 2018 Feb 06; 18(1):141. PubMed ID: 29409452
    [Abstract] [Full Text] [Related]

  • 16. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.
    Oncol Rep; 2013 Jul 06; 30(1):320-6. PubMed ID: 23673725
    [Abstract] [Full Text] [Related]

  • 17. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.
    Godfrey AC, Xu Z, Weinberg CR, Getts RC, Wade PA, DeRoo LA, Sandler DP, Taylor JA.
    Breast Cancer Res; 2013 May 24; 15(3):R42. PubMed ID: 23705859
    [Abstract] [Full Text] [Related]

  • 18. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the Applicability of microRNAs in Peripheral Blood Leukocytes as Biomarkers of Sensitivity and Exposure to Fractionated Radiotherapy towards Breast Cancer.
    Marczyk M, Polańska J, Wojcik A, Lundholm L.
    Int J Mol Sci; 2021 Aug 13; 22(16):. PubMed ID: 34445424
    [Abstract] [Full Text] [Related]

  • 20. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
    Said MN, Muawia S, Helal A, Fawzy A, Allam RM, Shafik NF.
    Exp Mol Pathol; 2021 Dec 13; 123():104718. PubMed ID: 34752733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.